Only show
results from:





Sort results by:

Display preferences

868 results sorted by relevancy Results per page:
Avigen Appoints Glenn Pierce, Ph.D., M.D. Vice President, Clinical Development.
PR Newswire; Nov 18, 2002; 700+ Words ...Hemophilia and Parkinson's Disease Avigen, Inc. today announced that Glenn Pierce...development process. About Avigen Avigen, Inc., based in the San Francisco Bay...Director of Investor Relations of Avigen, Inc., +1-510-748-7112, lneedham...
Avigen Appoints Kenneth Chahine President and Chief Executive Officer.
PR Newswire; Mar 9, 2004; 700+ Words Avigen, Inc. today announced that Ken Chahine, Ph...neurological disorders." About Avigen: Avigen, Inc., based in the San Francisco Bay Area...Paulson, Chief Financial Officer of Avigen, Inc., +1-510-748-7150, or fax...
Avigen Symposium on Gene Therapy for CNS Disorders to be Webcast; Experts to Review New Treatment Paradigms for Parkinson's Disease and Neuropathic Pain.
PR Newswire; Jan 29, 2004; 700+ Words Avigen, Inc. a leader in the development of gene...10 Based Gene Therapy) About Avigen Avigen, Inc., based in the San Francisco Bay Area...Paulson, Chief Financial Officer of Avigen, Inc., +1-510-748-7150, or fax...
Avigen Cleared by FDA to Begin Gene Therapy Trial for Parkinson's Disease.
PR Newswire; Aug 12, 2004; 700+ Words ...Dopa in Late Stages of Illness Avigen Inc., today announced that the Food...www.avigen.com/ About Avigen Avigen, Inc., based in the San Francisco Bay...Paulson, Chief Financial Officer of Avigen, Inc., +1-510-748-7150, or...
Avigen Implements Restructuring Plan to Support Realigned Strategy and Conserve Financial Resources.
PR Newswire; Jul 15, 2004; 700+ Words Avigen, Inc. announced today it has implemented a...pain in established preclinical models. Avigen, Inc., based in the San Francisco Bay Area...Paulson, Chief Financial Officer of Avigen, Inc., +1-510-748-7150, or fax...
Avigen Proceeds With Liver Infusion of Coagulin-B(TM) Therapy For Hemophilia B.
PR Newswire; Feb 4, 2002; 700+ Words SAN FRANCISCO -- Avigen, Inc. announced today that it is proceeding...in the San Francisco Bay Area, Avigen, Inc. is a biotechnology company involved...Paulson, Chief Financial Officer of Avigen, Inc., +1-510-740-7150, or...
Avigen Appoints Dawn McGuire, M.D. Chief Medical Officer; Noted Clinician in Multiple Therapeutic Areas to Lead Clinical Trials.
PR Newswire; Jan 14, 2004; 700+ Words Avigen, Inc. today announced that Dawn McGuire...therapies to patients." About Avigen Avigen, Inc., based in the San Francisco Bay Area...Paulson, VP and Chief Financial Officer of Avigen, Inc., +1-510-748-7150, or fax...
Avigen's AV650 Patent Strategy Leads to Expanded Development Agreement.
PrimeZone Media Network; Jul 23, 2008; 700+ Words ...Jul 23, 2008 (PrimeNewswire via COMTEX) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company...Avigen, consult the company's website at www.avigen.com. The Avigen, Inc. logo is available at http://www.primenewswire...
Avigen's gene therapy technology acquired by Genzyme.
BIOTECH Patent News; Dec 1, 2005; 700+ Words Avigen, Inc. (Alameda, CA)has agreed...Genzyme will acquire all of Avigen's non-pain related AAV...partnership with Excigen, Inc., atrial fibrillation...Genetic Technologies. Among the Avigen assets being acquired by Genzyme...
Avigen's Gene Therapy Technology Acquired by Genzyme.
PR Newswire; Dec 21, 2005; 700+ Words ...all Products Developed - Avigen CEO to Host Conference...PRNewswire-FirstCall/ -- Avigen, Inc. announced today that...partnership with Excigen, Inc., atrial fibrillation...Technologies. Among the Avigen assets being acquired by...
Avigen Retains Independent Strategic Advisors.
GlobeNewswire; Jan 14, 2009; 700+ Words ...Jan 14, 2009 (GlobeNewswire via COMTEX) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company...Avigen, consult the company's website at www.avigen.com. The Avigen, Inc. logo is available at http://www.globenewswire...
Avigen to Present At RBC Capital Markets Healthcare Conference; Presentation Scheduled for 8:00 a.m. (EST) On Wednesday, December 10, 2008.(Conference news)
GlobeNewswire; Dec 3, 2008; 700+ Words ...GlobeNewswire via COMTEX) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical...website at www.avigen.com. The Avigen, Inc. logo is available at http...www.globenewswire.com SOURCE: Avigen, Inc. Avigen, Inc. Michael Coffee...
Avigen Implements Strategic Plan to Extend Cash to Four to Five Years.
PR Newswire; Oct 22, 2002; 700+ Words Avigen, Inc. announced today a new strategic plan...30, 2002 as scheduled. About Avigen Avigen, Inc., based in the San Francisco Bay Area...Associate Director of Investor Relations of Avigen, Inc., +1-510-748-7112, or lneedham...
Avigen Reports Results for the First Quarter Ended March 31, 2003.
PR Newswire; Apr 30, 2003; 700+ Words Avigen, Inc. , the leader in AAV gene delivery technology...webcast will be available for 30 days. About Avigen Avigen, Inc., based in the San Francisco Bay Area, is a...caption "Risk Factors" in Item 1 of that report. AVIGEN, INC.
Avigen Exclusively Licenses Technology for the Treatment of Chronic Pain; Expands Existing Research Collaboration into New Pain Paradigm.
PR Newswire; Dec 8, 2003; 700+ Words Avigen, Inc. announced today that it has exclusively...executed with industry." About Avigen Avigen, Inc., based in the San Francisco Bay Area...Associate Director of Investor Relations of Avigen, Inc., +1-510-748-7112, or lneedham...
Avigen's Stockholders Deny BVF's Bid to Remove Board of Directors in Proxy Fight; Avigen's Board Will Pursue the Full-Value of its Assets for Stockholders.
GlobeNewswire; Mar 31, 2009; 700+ Words ...GlobeNewswire via COMTEX) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical...website at www.avigen.com. The Avigen, Inc. logo is available at http...www.globenewswire.com SOURCE: Avigen, Inc. Avigen, Inc. Andrew Sauter...
Avigen to Hold Conference Call Today to Discuss Licensing of Unique Neuroactive Compound for Disabling Neuromuscular Conditions.
PR Newswire; Jan 17, 2006; 700+ Words ...17 /PRNewswire-FirstCall/ -- Avigen, Inc. will hold a conference call today...Michael Coffee, Chief Business Officer of Avigen, Inc., +1-510-748-7372 Web site: http://www.avigen.com/
Avigen, Inc./.
PR Newswire; Dec 15, 2000; 700+ Words ...December 18, 2000 Researchers and Avigen Management Will Provide Review of...Calif., Dec 13 /PRNewswire/ -- Avigen, Inc. (Nasdaq: AVGN), announced...in the San Francisco Bay area, Avigen, Inc. is a biotechnology company involved...
Avigen Granted Broad Hemophilia A Gene Therapy Patent.
PR Newswire; Mar 14, 2001; 700+ Words ...Strategies for AAV Vector Delivery Avigen Gene Therapy Patents Now Broadly...Calif., March 14 /PRNewswire/ -- Avigen, Inc. (Nasdaq: AVGN) today announced...vectors. This new patent rounds out Avigen's hemophilia A and B patent portfolio...
Avigen Reports Financial Results for the Three and Nine Months Ended September 30, 2002.
PR Newswire; Oct 30, 2002; 700+ Words ...and Securities of $126 Million Avigen, Inc. , the leader in AAV gene delivery...during the periods. About Avigen Avigen, Inc., based in the San Francisco Bay...Factors" in Item 1 of that report. AVIGEN, INC. SELECTED FINANCIAL INFORMATION...
868 results: 1 | 2 | 3 | 4 | 5 | Next >>